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Abstract
Background: Humans are exposed to nitrate predominantly through diet with peak plasma concentrations
within an hour after ingestion, but additional exposure is obtained from the environment, and minimally
through de novo synthesis. Higher nitrate consumption has been associated with methemoglobinemia,
spontaneous abortions, atherosclerosis, myocardial ischemia, septic and distressed lung, inflammatory bowel
disease, amyotrophic lateral sclerosis, and neural tube defects. However, skeletal muscle development has not
been examined.
Methods: C2C12 skeletal muscle cell cultures were maintained, myoblasts were fused into myotubes, and
then cultures were exposed to motor neuron derived agrin to enhance acetylcholine receptor (AChR) clustering.
Untreated cultures were compared with cultures exposed to sodium nitrate at concentrations ranging from
10 ng/mL–100 μg/mL.
Results: The results reported here demonstrate that 1 μg/mL sodium nitrate was sufficient to decrease the
frequency of agrin-induced AChR clustering without affecting myotube formation. In addition, concentrations
of sodium nitrate of 1 μg/mL or 100 μg/mL decreased gene expression of the myogenic transcription factor
myogenin and AChR in correlation with the agrin-induced AChR clustering data.
Conclusions: These results reveal that sodium nitrate decreases the frequency of agrin-induced AChR clustering by a
mechanism that includes myogenin and AChR gene expression. As a consequence sodium nitrate may pose a risk for
skeletal muscle development and subsequent neuromuscular synapse formation in humans.
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Background
For over 70 years methemoglobinemia in infants has been
linked to nitrate consumption [1, 2]. Normally a small
percentage of hemoglobin exists as methemoglobin (about
1–2 %), which is due to genetic factors or chemical expos-
ure and typically does not result in health issues. When
that percentage increases, methemoglobinemia may result,
decreasing the oxygen carrying capacity and distribution
by the affected hemoglobin. Nitrate reduced to nitrite will
oxidize ferrous iron causing a shift to methemoglobin
which has been linked to methemoglobinemia in infants
whose formula was made with well water [1]. Not all in-
fants developed methemoglobinemia and so it is believed
that the involvement of nitrate or nitrite is a cofactor in
this disease [2].
Correlations between nitrate intake and gestational
complications such as increased spontaneous abortions
have been noted [3]. Studies in animals have shown that
nitrate, nitrite and N-nitroso compounds are all capable
of crossing the placenta [4–6], and there have been cases
of abortions in pigs pastured or housed in feedlots with
oats and rape containing high levels of nitrates, 0.53 %
and 5.52 % respectively [7]. Studies have considered
whether or not nitrate is involved in spontaneous abor-
tions in humans [3, 8]. A study in Bulgaria found that
women with high nitrate exposure suffered from one or
more complications, with 67 % having anemia, 23 %
toxemia, and 33 % spontaneous abortions or premature
delivery. Of the population studied only 16 % had a
normal pregnancy [9].
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Gastric generation of nitrotyrosines from increased
nitrite intake have been detectable in vivo and have been
found in tissues associated with multiple pathologies:
atherosclerosis, myocardial ischemia, septic and distressed
lung, inflammatory bowel disease, and amyotrophic lateral
sclerosis [10, 11]. In addition, higher rates of neural tube
defects have been reported for fetuses of pregnant women
who took nitrosatable drugs or drank water with higher
levels of nitrate [12].
Humans are exposed to nitrate predominantly through
diet with peak plasma concentrations 60 min after inges-
tion [13]. Some nitrate exposure is obtained from the en-
vironment, and additionally (though minimally) through
de novo synthesis. In the diet consumption is primarily
from fruits and vegetables, which comprise 60–80 % of
the nitrate ingested [14]. A secondary source of dietary
consumption is cured meats. Sodium nitrate and its
reduced form sodium nitrite are used by the meat industry
to prevent microbial growth (namely c. botulinum) and
retain the color of preserved and cured meats [14]. Dietary
intake is estimated at 50–140 mg/day in Europe and
40–100 mg/day in the United States [15].
De novo synthesis of nitrate has been estimated to
range from 500 to 1000 μmol/day [16, 17]. In a study
where human subjects consumed a diet with slightly less
than average nitrate levels, endogenous nitrate was re-
ported at an average of 870 μmol/day [18]. The higher
estimate of 1000 μmol/day translates into 62 mg/day,
and when combined with estimates of dietary intake
[15], the total nitrate exposure could be as high as
200 mg/day in Europe and 160 mg/day in the United
States. Another study using 15NO3
− determined that
endogenous nitrate production occurred at all levels
of ingestion, however at higher levels of intake endogen-
ous production was masked [16]. The level of nitrate
intake per day varies depending on age, gender, race/
ethnicity, BMI and level of education [19].
Skeletal muscle development in fetuses of pregnant
women exposed to high nitrate levels has not been ex-
amined. During skeletal muscle development, myoblasts
proliferate and fuse to form multinucleated myotubes.
Acetylcholine receptors (AChR) will cluster spontaneously
but aggregation increases upon exposure to motor neuron
derived agrin [20–22], as AChRs become part of the post-
synaptic component of the neuromuscular synapse. In
addition, the myogenic regulatory factor myogenin acti-
vates genes for AChR subunits [23, 24], suggesting that
myogenic regulatory factors like myogenin are intricately
linked to the development of the postsynaptic component.
Exposure to nicotine, caffeine, ethanol, and mercury have
been demonstrated to decrease AChR clustering in C2C12
myotubes [25–28], whereas methoxychlor has been dem-
onstrated to decrease myotube formation by slowing myo-
blast proliferation without affecting AChR clustering [29].
The objective of the current study was to investigate
whether sodium nitrate affects skeletal muscle develop-
ment, specifically the events of myoblast fusion into
myotubes and AChR clustering. And if there is an effect,
does sodium nitrate mediate that effect by interfering
with myogenin or AChR expression. Skeletal muscle cell
cultures, such as the C2C12 cell line derived from
mouse hindlimb, provide simplified systems for studying
development of the postsynaptic component of the neuro-
muscular synapse [30, 31]. The C2C12 cell culture model
has proven useful for asking fundamental questions
concerned with muscle development and neuromuscu-
lar synapse formation, and is ideal for examining how
sodium nitrate might interfere with these developmen-
tal events. The results reported here demonstrate that
1 μg/mL sodium nitrate was sufficient to decrease the
frequency of agrin-induced AChR clustering without
affecting myotube formation. In addition, sodium ni-
trate decreased myogenin and AChR gene expression in




C2C12 myoblasts were derived from mouse hind limb
(gift from H. Gordon, University of Arizona) [30, 31],
and are commonly used for skeletal muscle cell culture
experiments. They are ideal for studying myoblast fusion
to form myotubes, and acetylcholine receptor (AChR)
clustering. For normal maintenance of C2C12 cell cul-
ture, myoblasts were first plated in growth medium
(GM) on 10 cm plates at approximately 20 % confluence.
GM consists of Dulbecco’s modified Eagle’s medium
(DMEM) plus 20 % fetal bovine serum, 0.5 % chick
embryo extract and 100 U/mL penicillin. Fresh GM was
added daily, and myoblast cultures were split into new
plates at approximately 60 % confluence. For formation
of myotubes, myoblasts were plated in GM on 22×22 mm
cover slips that had been flamed in 200-proof ethanol and
placed in 6-well plates. Fresh GM was added daily. After
48 h in GM, myoblast cultures typically reached 90 %
confluence, and cultures were then switched to differenti-
ation medium (DM). DM consists of DMEM plus 2 %
horse serum and 100 U/mL penicillin. Fresh DM was
added daily as myoblasts fused to form myotubes, and
cultures were maintained for 72 h in DM. All cultures
were exposed to 10 ng/mL agrin (R&D Systems) for the
last 16 h of 72 h in DM to induce AChR clustering. Some
cultures were exposed to 10 ng/mL–100 μg/mL sodium
nitrate (NaNO3; Sigma-Aldrich) for the last 48 h of 72 h
in DM. A 1 g/mL NaNO3 stock solution was prepared in
DM and then serial dilutions were performed to achieve
the treatment concentrations. It would be difficult to
correlate nitrate dietary intake and endogenous nitrate
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production with nitrate treatment in cell culture. At best
cell culture might mirror fetal exposure to toxins in
maternal blood to some degree. Therefore, a range of
NaNO3 concentrations were tested in cell culture to inves-
tigate any effect on AChR clustering, myotube formation,
and myogenin and AChR gene expression.
Acetylcholine receptor clustering assay
AChRs were labeled by the binding of α-bungarotoxin
conjugated to tetramethyl rhodamine (Molecular Probes)
[32]. Cultures were incubated in the toxin-containing
medium for 30 min at 37 °C to label AChRs after 72 h
in DM. The cover slips were rinsed three times with
room temperature phosphate buffered saline (PBS), fixed
for 10 min with 2 % paraformaldehyde in PBS, rinsed
three times with PBS, dehydrated in cold methanol for
5 min at −20 °C, and mounted on microscope slides in
Vectashield Mounting Medium for Fluorescence (Vec-
tor Laboratories). For some experiments the mounting
medium contained 4’6-diamidino-2-phenylindole (DAPI)
to visualize nuclei. AChR clusters were visualized with an
IX70 Olympus inverted microscope under the 20X object-
ive (yielding a total magnification of 200X), and fluores-
cent images were captured as high-resolution JPG files
with an Olympus camera with Magnafire digital imaging
software. Bright clusters of AChRs were observed on all
aspects of myotubes in fluorescent images. AChR clusters
were counted from 25 images captured from each cover
slip using ImageJ software. One cover slip was analyzed
for each treatment group in each replicate experiment.
These data were utilized to assay agrin-induced AChR
clustering in untreated cultures, or after exposure to
10 ng/mL–100 μg/mL NaNO3 for the last 48 h of 72 h in
DM. Comparisons of untreated cultures with cultures
exposed to NaNO3 were analyzed by Student’s t-test to
determine statistically different results at p < 0.05. Repre-
sentative images were assembled into Fig. 2.
Myotube formation index
Cell cultures were visualized with an IX70 Olympus
inverted microscope under the 20X objective (yielding
a total magnification of 200X), and representative phase
contrast and DAPI images were captured as high-
resolution JPG files with an Olympus camera with
Magnafire digital imaging software. Composite images
were created through GNU Image Manipulation Pro-
gram (GIMP 2) which was used to identify myoblasts
(defined as cells with one or two nuclei) or myotubes
(defined as cells with three or more nuclei). DAPI
staining was used to observe and count nuclei. These
images were utilized to quantify myotube formation by
modifying a myoblast fusion index paradigm [33] into
a myotube formation index used in our laboratory
[26, 28, 29]. Six composite images were analyzed for
untreated cultures, and five composite images each
for cultures exposed to 1 μg/mL NaNO3 or 10 μg/mL
NaNO3 for the last 48 h of 72 h in DM. The myotube for-
mation index was then calculated as the fraction of nuclei
in myotubes, with the data displayed in Table 1.
Western blots
To assay for protein levels of the myogenic regulatory
factor myogenin or AChR, myotube cultures were di-
vided into untreated cultures, and those that had been
exposed to 10 ng/mL, 1 μg/mL, or 100 μg/mL NaNO3
for the last 48 h of 72 h in DM. Myotube cultures were
rinsed twice with calcium- and magnesium-free PBS
(CMF-PBS), scraped off in RIPA complete lysis buffer
(containing PMSF, sodium orthovanadate, and protease
inhibitors), agitated for 30 min on ice, and then centri-
fuged at 13,000 g for 2 min to create pellets containing
insoluble materials such as organelles and extracellular
matrix. The extracted supernatant was then frozen. At a
later time samples were thawed, a BCA protein assay
was performed to determine the concentration of pro-
tein in each sample, and samples were boiled for 5 min
in sample buffer to reduce and denature proteins. Then
samples were separated by electrophoresis on a 10 %
polyacrylamide gel (Bio-Rad) and transferred to a nitro-
cellulose membrane. The membranes were blocked with
5 % milk in TBS-T, with some membranes probed for
16 h at 4 °C with a mouse monoclonal antibody to myo-
genin (sc-12732; Santa Cruz Biotechnology) at 1:1000 in
blocking solution, and then probed by a goat anti-mouse
secondary antibody (926–32210; Li-Cor) at 1:10,000 in
blocking solution for 30 min. Other membranes were
probed for 16 h at 4 °C with a rabbit polyclonal antibody
to AChR (SC-11372; Santa Cruz Biotechnology) at
1:1000 in blocking solution, and then probed by a goat
anti-rabbit secondary antibody (926–68071; Li-Cor) at
1:10,000 in blocking solution for 30 min. The resultant
western blot was then visualized with the Odyssey CLx,
a near infrared imaging system. It uses solid state diode
lasers to excite at 685 and 785 nm. For scanning, the
western blot was placed on the glass surface of the
odyssey and covered with a rubber mat. In the Li-Cor
software a box was created to define the scanning area
of the blot. The 700 and 800 channels were chosen and
low quality image quality and 169 μm resolution was
checked before “start scan” was pressed. As a loading









Untreated (n = 6) 2440 2177 263 0.8922
1 μg/ml NaNO3 (n = 5) 2372 2088 284 0.8803
10 μg/ml NaNO3 (n = 5) 1917 1653 264 0.8623
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control, all samples were also probed with a mouse
monoclonal antibody to actin (sc-8432; Santa Cruz Bio-
technology). The ratio of myogenin or AChR signal to
actin signal could then be calculated and compared across
treatment groups, along with the percent reduction in this
ratio for treatment groups compared to untreated cul-
tures. The western blot data and agrin-induced AChR
clustering data is displayed in Table 2.
Results
NaNO3 decreases the frequency of agrin-induced AChR
clusters
AChRs cluster spontaneously with a baseline frequency
on C2C12 myotubes and this clustering is increased
with agrin treatment [20–22]. C2C12 cell cultures were
switched from GM to DM at 90 % confluence, 10 ng/mL
agrin was added for the last 16 h in DM, and myotubes
were examined for AChR clustering after 72 h in DM.
Some cultures were left untreated (control cultures), while
others were exposed to 10 ng/mL–100 μg/mL NaNO3 for
the last 48 h of 72 h in DM. For each experiment one
cover slip was analyzed for each treatment group or
control. AChR clusters were counted from 25 images
captured from each cover slip using ImageJ software. One
cover slip was analyzed for each treatment group in
each replicate experiment, with typical data sets re-
ported (Figs. 1 and 2). 1 μg/mL NaNO3 was sufficient
to decrease the frequency of agrin-induced AChR clus-
tering, with statistical significance at p < 0.05 using
Student’s t-test.
NaNO3 has no effect on myotube formation
Myotube formation was quantified by modifying a myo-
blast fusion index paradigm [33] into a myotube forma-
tion index used in our laboratory [26, 28, 29]. Composite
images were created through GNU Image Manipulation
Program (GIMP 2) which was used to identify myoblasts
(defined as cells with one or two nuclei) or myotubes
(defined as cells with three or more nuclei), and then
analyzed as described in the Methods and Fig. 3 legend.
The myotube formation index was then calculated as the
fraction of nuclei in myotubes and presented in Table 1 as
a summary of the data collected. The fraction of nuclei in
myotubes was unaffected by exposure to 1 μg/mL NaNO3
or 10 μg/mL NaNO3 for the last 48 h of 72 h in DM.
NaNO3 decreases myogenin and AChR gene expression
The myogenic regulatory factor myogenin activates genes
for AChR subunits [23, 24]. This suggests that myogenic
regulatory factors like myogenin are intricately linked to
the development of the AChR postsynaptic component of
the neuromuscular synapse. Therefore a decrease in the fre-
quency of agrin-induced AChR clusters could have many
causes. First, NaNO3 may decrease AChR gene expression,
directly reducing AChR available for agrin-induced cluster-
ing of AChRs. Second, NaNO3 may decrease myogenin ex-
pression, making less myogenin available to activate genes
for AChR subunits, indirectly reducing AChR available for
agrin-induced clustering of AChRs. Alternately, a decrease
in myogenin gene expression could lead to decreased acti-
vation of other genes necessary for AChR clustering with
or without an effect on AChR gene expression. Finally,
NaNO3 may decrease AChR clustering through a mechan-
ism that does not affect the level of AChR gene expression.
Western blots were used to measure the amount of myo-
genin protein and AChR protein. C2C12 cell cultures were
exposed to 10 ng/mL, 1 μg/mL, or 100 μg/mL NaNO3 for
the last 48 h of 72 h in DM, with representative western
blots presented (Fig. 4). NaNO3 decreased myogenin
and AChR gene expression in correlation with the
agrin-induced AChR clustering data. For the represen-
tative experiment in Fig. 4, this correlation is detailed
in Table 2.
Table 2 Comparison of NaNO3 effects
Myogenin expression Myogenin expression signal Actin expression signal Myogenin/Actin ratio Percent compared with untreated
Untreated 1170 1630 0.7178
1 μg/ml NaNO3 1360 2130 0.6385 89 %
100 μg/ml NaNO3 1030 2640 0.3902 54 %
AChR expression AChR expression signal Actin expression signal AChR/Actin ratio Percent compared with untreated
Untreated 2490 3610 0.6898
1 μg/ml NaNO3 1910 4590 0.4161 60 %
100 μg/ml NaNO3 2340 9320 0.2511 36 %
Agrin-induced AChR clustering AChR clusters per field
of view
Percent compared with untreated
Untreated 19.24
1 μg/ml NaNO3 9.14 48 %
100 μg/ml NaNO3 7.42 39 %
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Discussion
The results reported here demonstrate that sodium nitrate
decreases the frequency of agrin-induced acetylcholine re-
ceptor (AChR) clustering in correlation with a decrease in
myogenin and AChR gene expression. This suggests that
sodium nitrate may interfere with normal developmental
events by initially decreasing myogenin gene expression,
which causes a decrease in AChR gene expression, and
ultimately results in fewer AChRs available to cluster in
response to agrin stimulation.
Myogenin is one of several myogenic transcription
factors that guide skeletal muscle development. Myo-
genin directly activates rapsyn gene expression [34] and
the genes for AChR subunits [23, 24]. Rapsyn is one of
several postsynaptic molecules that is essential for the
formation of AChR clusters during neuromuscular syn-
apse formation [35]. Another is a muscle specific kinase
(MuSK) that is essential for the signaling events that pre-
cede AChR clustering [36–39]. These signaling events are
initiated when motor neuron derived agrin binds to low-
density lipoprotein receptor-related protein (Lrp4) [40, 41]
to stimulate tyrosine phosphorylation of MuSK [38] and
the subsequent signaling pathway that includes the
tyrosine phosphorylation of the AChR β subunit leading
to increased AChR clustering [42, 43]. Suppression of
Lrp4 gene expression decreases agrin binding activity,
agrin-induced MuSK tyrosine phosphorylation, and agrin-
induced AChR clustering [41].
Fig. 2 Examples of cell cultures exposed to NaNO3. Fluorescent images were captured from agrin-induced cultures that were untreated (a), or
exposed for the last 48 h of 72 h in DM to 10 μg/mL NaNO3 (b), 1 μg/mL NaNO3 (c), or 100 ng/mL NaNO3 (d). Fluorescent areas are clusters of
AChRs. Scale bar = 100 μm
Fig. 1 NaNO3 decreases the frequency of agrin-induced AChR clusters.
Frequency of agrin-induced AChR clusters were quantified by analyzing
fluorescent images from agrin-induced cultures that were untreated or
were exposed to 10 ng/mL-100 μg/mL NaNO3 for the last 48 h of 72 h
in DM. The histogram reveals that exposure to 1 μg/mL NaNO3 was
sufficient to decrease agrin-induced AChR clusters relative to untreated
cultures, using Student’s t-test at p < 0.05. (*) statistically decreased
from untreated cultures. Error bar indicates standard error of the
mean (s.e.m.)
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In the data reported in Table 2, when compared with
untreated cell cultures, treatment with 1 μg/ml sodium
nitrate decreased myogenin gene expression to 89 %
of the untreated level, and treatment with 100 μg/ml
sodium nitrate decreased myogenin gene expression
to 54 % of the untreated level. This correlated with a
consequent decrease in AChR gene expression to 60 % of
the untreated level with 1 μg/ml sodium nitrate treatment,
and a decrease to 36 % of the untreated level with
100 μg/ml sodium nitrate treatment. Decreases in
myogenin and AChR gene expression also correlated
with decreased agrin-induced AChR clustering, where
treatment with 1 μg/ml sodium nitrate decreased agrin-
induced AChR clustering to 48 % of the untreated level,
and treatment with 100 μg/ml sodium nitrate decreased
agrin-induced AChR clustering to 39 % of the untreated
level. This data shows that the level of agrin-induced
AChR clustering is directly correlated with the level of
AChR gene expression, supporting the interpretation that
with sodium nitrate treatment fewer AChRs are available
to cluster in response to agrin stimulation. Finally, with
sodium nitrate treatment of 0.01 μg/ml agrin-induced
AChR clustering and myogenin gene expression were
unaffected, while AChR gene expression was decreased to
66 % of the untreated level (data not shown), suggesting
AChR gene expression is more sensitive to sodium nitrate
Fig. 3 Composite images were created through GNU Image Manipulation Program (GIMP 2) which was used to identify myoblasts (defined as
cells with one or two nuclei) or myotubes (defined as cells with three or more nuclei). Phase contrast images were captured to visualize myotubes and
myoblasts (a), while fluorescent images were captured to label nuclei with dots (b) and visualize nuclei with DAPI (c). These layers were combined into
a composite image (d). An example of a composite image with nuclei in myoblasts labeled with yellow (large) dots and nuclei in myotubes labeled
with red (small) dots to allow for quantification of fraction of nuclei in myotubes is included (e). Scale bar = 100 μm
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levels than myogenin gene expression and that AChR
gene expression is not the sole determinant of agrin-
induced AChR clustering.
Myogenin was previously shown to be essential for
myoblast differentiation [44, 45]. In the data reported
here, concentrations of sodium nitrate as high as 10 μg/ml
had no effect on myotube formation. The fraction of
nuclei in myotubes was 0.8922 for untreated cultures,
0.8803 for cultures treated with 1 μg/ml sodium nitrate,
and 0.8623 for cultures treated with 10 μg/ml sodium ni-
trate. In contrast, concentrations as low as 1 μg/ml were
sufficient to decrease agrin-induced AChR clustering. This
may reflect a difference in sensitivity to myogenin levels
between myotube formation and agrin-induced AChR
clustering. Alternately, this may reflect the time sequence,
since myotube formation occurs prior to synapse for-
mation and AChR clustering in normal skeletal muscle
development. A previous study showed that treatment
of C2C12 cells with myogenin antibodies also decreased
agrin-induced AChR clustering without affecting myo-
tube formation [46].
The reduction in AChR clustering caused by sodium
nitrate could have a functional outcome similar to com-
mon neuromuscular disorders. As an example, patients
with the autoimmune disease myasthenia gravis have
muscle weakness due to a decrease in functional AChRs.
In contrast, patients with muscular dystrophy have muscle
weakness due to neuromuscular synapses that have re-
duced or absent postsynaptic molecules other than AChRs.
However the functional outcome is the same, muscle
weakness. The data reported here suggests that any disease
process that affects myogenin gene expression could also
lead to muscle weakness due to a decrease in AChR clus-
tering at neuromuscular synapses caused by a decrease in
AChR gene expression. For further inquiry it might be
useful to replicate these experiments using other cell lines
including human muscle cell lines to see if the results are
universal across species.
Conclusions
The results reported here demonstrate that 1 μg/mL so-
dium nitrate was sufficient to decrease the frequency of
agrin-induced AChR clustering without affecting myo-
tube formation. In addition, sodium nitrate decreased
myogenin and AChR gene expression in correlation with
the agrin-induced AChR clustering data. These results
demonstrate that sodium nitrate decreases the frequency
of agrin-induced AChR clustering by a mechanism that
includes myogenin and AChR gene expression. As a
consequence sodium nitrate may pose a risk for skeletal
muscle development and subsequent neuromuscular
synapse formation in humans.
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Fig. 4 NaNO3 decreased myogenin and AChR gene expression in correlation with the agrin-induced AChR clustering data. Untreated agrin-induced
cultures were compared with cultures exposed to 10 ng/mL, 1 μg/mL, or 100 μg/mL NaNO3 for the last 48 h of 72 h in DM. Cultures were assayed for
the amount of myogenin or AChR protein and compared with an actin control. The data correlating these two effects of NaNO3 is detailed in Table 2.
These results demonstrate that NaNO3 decreases the frequency of agrin-induced AChR clustering by a mechanism that causes decreased myogenin
and AChR gene expression
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